Ministry of Health and Family Welfare press release · 21 May 2026 · pibtracker filter

1st ICMR Annual Clinical Trial Meet 2026 highlights India’s emerging leadership in integrative medicine research

PRID2263574 MinistryMinistry of Health and Family Welfare Released21 May 2026 Reading10 min

ICMR launches report to strengthen First-in-Human Phase 1 clinical trials in India Operational guidelines for single ethics review of multicentre research launched Experts deliberate on strengthening India’s clinical research and regulatory ecosystem Posted On: 21 MAY 2026 11:35AM by PIB Delhi The Indian Council of Medical Research successfully organised the “1st ICMR Annual Clinical Trial Meet 2026” on May 20, 2026, under the theme “International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials.” The national-level event served as a significant platform for deliberations on strengthening India’s clinical trial ecosystem and advancing evidence-based integrative medicine research in the country. The meet brought together policymakers, scientists, clinicians, researchers, regulatory authorities and experts from diverse fields to discuss emerging opportunities, ethical frameworks, regulatory pathways and innovations in clinical research. The programme was graced by Prof. (Dr.) V. K. Paul, Dr. Rajiv Bahl and Vaidya Rajesh Kotecha along with eminent experts and stakeholders from the healthcare and scientific community. Addressing the gathering, the dignitaries highlighted the need for robust clinical research systems, ethical governance and scientific validation of integrative healthcare practices to address emerging public health challenges and strengthen healthcare delivery mechanisms in the country. One of the major highlights of the event was the presentation of findings from the ICMR-CCRAS multicentric Phase III Randomized Controlled Trial (RCT) on Iron Deficiency Anaemia. The study evaluated integrative approaches for managing anaemia, a major public health concern in India. The clinical trial compared the efficacy of Punarnavadi Mandura alone and in combination with Drakshavaleha against standard Iron Folic Acid supplementation. Conducted among nearly 4,000 non-pregnant women aged 18–49 years with moderate anaemia, the study assessed haemoglobin levels and clinical outcomes over a period of 90 days. The findings demonstrated that both Ayurvedic formulations were therapeutically equivalent to standard iron-folic acid therapy. The event also witnessed the launch of the report titled “Advancing First-in-Human Phase 1 Clinical Trials in India: A Delphi Study on Regulatory Pathways and Opportunities.” The report was developed through a two-round consultation involving 37 experts from the pharmaceutical industry, Contract Research Organisations (CROs), academia and national regulatory agencies. The study identified major bottlenecks affecting the advancement of early-phase clinical trials in India and recommended measures including strengthening regulatory capacity, streamlining approval processes and enhancing coordination among agencies to support innovation-driven clinical research in the country. Another important milestone during the event was the release of the “Operational Guidelines for Single Ethics Review of Multicentre Research in India,” aimed at strengthening and harmonising ethical review mechanisms for multicentre research studies nationwide. A panel discussion on “Policy Uptake of Integrative Research Evidence” was also organised during the programme. The discussion facilitated meaningful deliberations on translating scientific evidence into public health policy and healthcare practice. The Annual Clinical Trial Meet reaffirmed ICMR’s commitment towards fostering collaboration, strengthening ethical and regulatory frameworks and promoting innovation and scientific excellence in India’s clinical research ecosystem. *** SR/GS (Release ID: 2263574) Visitor Counter : 956 Read this release in: Urdu , हिन्दी , Punjabi , Gujarati , Tamil , Telugu Ministry of Health and Family Welfare 1st ICMR Annual Clinical Trial Meet 2026 highlights India’s emerging leadership in integrative medicine research ICMR launches report to strengthen First-in-Human Phase 1 clinical trials in India Operational guidelines for single ethics review of multicentre research launched Experts deliberate on strengthening India’s clinical research and regulatory ecosystem Posted On: 21 MAY 2026 11:35AM by PIB Delhi The Indian Council of Medical Research successfully organised the “1st ICMR Annual Clinical Trial Meet 2026” on May 20, 2026, under the theme “International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials.” The national-level event served as a significant platform for deliberations on strengthening India’s clinical trial ecosystem and advancing evidence-based integrative medicine research in the country. The meet brought together policymakers, scientists, clinicians, researchers, regulatory authorities and experts from diverse fields to discuss emerging opportunities, ethical frameworks, regulatory pathways and innovations in clinical research. The programme was graced by Prof. (Dr.) V. K. Paul, Dr. Rajiv Bahl and Vaidya Rajesh Kotecha along with eminent experts and stakeholders from the healthcare and scientific community. Addressing the gathering, the dignitaries highlighted the need for robust clinical research systems, ethical governance and scientific validation of integrative healthcare practices to address emerging public health challenges and strengthen healthcare delivery mechanisms in the country. One of the major highlights of the event was the presentation of findings from the ICMR-CCRAS multicentric Phase III Randomized Controlled Trial (RCT) on Iron Deficiency Anaemia. The study evaluated integrative approaches for managing anaemia, a major public health concern in India. The clinical trial compared the efficacy of Punarnavadi Mandura alone and in combination with Drakshavaleha against standard Iron Folic Acid supplementation. Conducted among nearly 4,000 non-pregnant women aged 18–49 years with moderate anaemia, the study assessed haemoglobin levels and clinical outcomes over a period of 90 days. The findings demonstrated that both Ayurvedic formulations were therapeutically equivalent to standard iron-folic acid therapy. The event also witnessed the launch of the report titled “Advancing First-in-Human Phase 1 Clinical Trials in India: A Delphi Study on Regulatory Pathways and Opportunities.” The report was developed through a two-round consultation involving 37 experts from the pharmaceutical industry, Contract Research Organisations (CROs), academia and national regulatory agencies. The study identified major bottlenecks affecting the advancement of early-phase clinical trials in India and recommended measures including strengthening regulatory capacity, streamlining approval processes and enhancing coordination among agencies to support innovation-driven clinical research in the country. Another important milestone during the event was the release of the “Operational Guidelines for Single Ethics Review of Multicentre Research in India,” aimed at strengthening and harmonising ethical review mechanisms for multicentre research studies nationwide. A panel discussion on “Policy Uptake of Integrative Research Evidence” was also organised during the programme. The discussion facilitated meaningful deliberations on translating scientific evidence into public health policy and healthcare practice. The Annual Clinical Trial Meet reaffirmed ICMR’s commitment towards fostering collaboration, strengthening ethical and regulatory frameworks and promoting innovation and scientific excellence in India’s clinical research ecosystem. *** SR/GS (Release ID: 2263574) ICMR launches report to strengthen First-in-Human Phase 1 clinical trials in India Operational guidelines for single ethics review of multicentre research launched Experts deliberate on strengthening India’s clinical research and regulatory ecosystem" /> The Indian Council of Medical Research successfully organised the “1st ICMR Annual Clinical Trial Meet 2026” on May 20, 2026, under the theme “International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials.” The national-level event served as a significant platform for deliberations on strengthening India’s clinical trial ecosystem and advancing evidence-based integrative medicine research in the country. The meet brought together policymakers, scientists, clinicians, researchers, regulatory authorities and experts from diverse fields to discuss emerging opportunities, ethical frameworks, regulatory pathways and innovations in clinical research. The programme was graced by Prof. (Dr.) V. K. Paul, Dr. Rajiv Bahl and Vaidya Rajesh Kotecha along with eminent experts and stakeholders from the healthcare and scientific community. Addressing the gathering, the dignitaries highlighted the need for robust clinical research systems, ethical governance and scientific validation of integrative healthcare practices to address emerging public health challenges and strengthen healthcare delivery mechanisms in the country. One of the major highlights of the event was the presentation of findings from the ICMR-CCRAS multicentric Phase III Randomized Controlled Trial (RCT) on Iron Deficiency Anaemia. The study evaluated integrative approaches for managing anaemia, a major public health concern in India. The clinical trial compared the efficacy of Punarnavadi Mandura alone and in combination with Drakshavaleha against standard Iron Folic Acid supplementation. Conducted among nearly 4,000 non-pregnant women aged 18–49 years with moderate anaemia, the study assessed haemoglobin levels and clinical outcomes over a period of 90 days. The findings demonstrated that both Ayurvedic formulations were therapeutically equivalent to standard iron-folic acid therapy. The event also witnessed the launch of the report titled “Advancing First-in-Human Phase 1 Clinical Trials in India: A Delphi Study on Regulatory Pathways and Opportunities.” The report was developed through a two-round consultation involving 37 experts from the pharmaceutical industry, Contract Research Organisations (CROs), academia and national regulatory agencies. The study identified major bottlenecks affecting the advancement of early-phase clinical trials in India and recommended measures including strengthening regulatory capacity, streamlining approval processes and enhancing coordination among agencies to support innovation-driven clinical research in the country. Another important milestone during the event was the release of the “Operational Guidelines for Single Ethics Review of Multicentre Research in India,” aimed at strengthening and harmonising ethical review mechanisms for multicentre research studies nationwide. A panel discussion on “Policy Uptake of Integrative Research Evidence” was also organised during the programme. The discussion facilitated meaningful deliberations on translating scientific evidence into public health policy and healthcare practice. The Annual Clinical Trial Meet reaffirmed ICMR’s commitment towards fostering collaboration, strengthening ethical and regulatory frameworks and promoting innovation and scientific excellence in India’s clinical research ecosystem. <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image001PG78.jpg" style="font-family:"Times New Roman",serif; font-size:16px; height:366px; width:780px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image00267S8.jpg" style="height:383px; width:780px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image0034Y8Z.jpg" style="height:670px; width:780px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image004EAPX.jpg" style="height:520px; width:780px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image0054WHG.jpg" style="height:520px; width:780px" /> *** SR/GS " /> var mPlayer = document.getElementById("background_music"); var mPlayAction = document.getElementById("playbutton"); var isPlaying = false; function playAudio() { mPlayer.play(); isPlaying = true; document.getElementById('stopA').style.display = "block"; document.getElementById('playA').style.display = "none"; } function pauseAudio() { mPlayer.pause(); isPlaying = false; document.getElementById('playA').style.display = "block"; document.getElementById('stopA').style.display = "none"; } //function HandleAudio() { // if (isPlaying == true) { // //Playing already Pause it // pauseAudio(); // } else { // //Play the music // playAudio(); // } //} var synth = window.speechSynthesis; function CleanHtml(html) { html = html.replace(/ /gi, ''); return html; } function stripHtml(html) { let tmp = document.createElement("DIV"); tmp.innerHTML = CleanHtml(html); return tmp.textContent || tmp.innerText || ""; } $(document).ready(function () { //for responsive tables $("table").each(function () { if (!$(this).closest(".table-responsive").length) { $(this).wrap(" "); } }); var width = $(window).width(); if (width $(document).ready(function () { var width = $(window).width(); if (width @media print { .sticky-social, .sticky-social_mb, .pull-right, #printPDF { display: none !important; } } .f_vl { padding-right: 30px; font-size: 17px; cursor: pointer; } .log_oo { // width: 20%; display: flex; justify-content: space-between; } .log_oo img { width: 150px; /*width: 100%; height: auto;*/ } .sticky-social_mb { position: fixed; bottom: 0px; padding: 0px; margin: 0px; width: 100%; } .social_mb { list-style: none; display: flex; width: 100%; margin-bottom: -8px; } .social_mb a { padding: 8px 0px; font-size: 30px; transition: all 0.8s ease-in-out; width: 20% !important; text-align: center; } .section1 { position: relative; padding: 10px 0px; width: 100%; } .sticky-social { position: fixed; top: 20px; left: 0px; padding: 0px; margin: 0px; } .social { list-style: none; } .social a li { padding: 8px 12px; font-size: 25px; transition: all 0.8s ease-in-out; } .social a li:hover { margin-right: -30px; box-shadow: 2px 5px 10px grey; } .social a li:hover .fa { margin-left: 20px; } .fb_b { /* background-color: rgb(59, 89, 152);*/ background-color: rgba(65,103,178,255); } .twitter_r { /* background-color: rgb(29, 161, 242);*/ background-color: #000000; } .whatsapp_r { /* background-color: rgb(77, 194, 71);*/ background-color: rgba(13,191,67,255); } .fa-envelope_r { /* background-color: rgb(219, 68, 55);*/ background-color: #e2123d; } .fa-linkedin_r { background-color: rgb(0, 119, 181); } @media only screen and (max-device-width: 767px) { p span img { max-width: 90% !important; height: auto !important; } p img { max-width: 90% !important; height: auto !important; } h2 { font-size: 20px !important; font-weight: 600 !important; } h3 { font-size: 18px !important; font-weight: 600 !important; } } /* === Film Roll Badge Styling(IFFI2025 countdown) === */ .film-roll-badge { position: absolute; top:82%; right: 20px; width: 230px; height: 70px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 18px, #6e2b8b 18px, #6e2b8b 36px ); border-top: 8px solid #9a2375; border-bottom: 8px solid #9a2375; border-radius: 8px; overflow: hidden; box-shadow: 0 4px 12px rgba(0, 0, 0, 0.4); animation: moveFilm 8s linear infinite; z-index: 10; } /* film sprocket holes */ .film-roll-badge::before, .film-roll-badge::after { content: ""; position: absolute; width: 100%; height: 10px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 10px, #fff 10px, #fff 20px ); left: 0; z-index: 2; } .film-roll-badge::before { top: -4px; } .film-roll-badge::after { bottom: -4px; } .film-roll-inner { position: relative; height: 100%; display: flex; align-items: center; justify-content: center; animation: flicker 2s infinite ease-in-out; } .countdown-text { font-size: 1.3rem; font-weight: 700; color: #fff; text-shadow: 0 0 6px rgba(255, 255, 255, 0.4), 0 0 10px #000; white-space: nowrap; } /* === Animations === */ @keyframes moveFilm { 0% { background-position: 0 0; } 100% { background-position: 120px 0; } } @keyframes flicker { 0%, 100% { opacity: 1; } 50% { opacity: 0.9; } 25% { opacity: 0.95; } 75% { opacity: 0.85; } } /* === Responsive Adjustments === */ @media (max-width: 1500px) { .film-roll-badge { top: 68%; right: 18px; /* width: 220px; */ height: 65px; font-size: 0.85rem; } .press-section { margin-top: 35px; } } @media (max-width: 992px) { .film-roll-badge { top: 52%; right: 10px; width: 200px; height: 60px; } } @media (max-width: 768px) { .film-roll-badge { top: 56%; right: 10px; width: 124px; height: 55px; } .countdown-text { font-size: 0.9rem; } } @media (max-width: 576px) { .film-roll-badge { top: 59%; right: 5px; /* width: 160px; */ height: 50px; } .countdown-text { font-size: 0.85rem; } } const festivalStart = new Date("2025-11-20T00:00:00").getTime(); const festivalEnd = new Date("2025-11-28T23:59:59").getTime(); const countdownElement = document.getElementById("countdown"); const interval = setInterval(() => { const now = new Date().getTime(); // BEFORE FESTIVAL — show days + hours left if (now = festivalStart && now el.style.width = "350px"); clearInterval(interval); } }, 1000); //

For UPSC

Remember "1st ICMR Annual Clinical Trial Meet 2026" held May 20, 2026; theme was integrative medicine; launched guidelines for single ethics review of multicentre research and First-in-Human Phase 1 trial strengthening report.

Original PIB release
pib.gov.in · PRID 2263574

Open on PIB ↗

1st ICMR Annual Clinical Trial Meet 2026 highlights India’s emerging leadership in integrative medicine research

For UPSC

More from this day